Prostate Cancer - Results from #1000

The spectrum of cutaneous toxicities related to novel genitourinary cancer therapies. June 25, 2024

Diagnostic Accuracy of 18F-Prostate Specific Membrane Antigen (PSMA) PET/CT Radiotracers in Staging and Restaging of Patients With High-Risk Prostate Cancer or Biochemical Recurrence: An Overview of Reviews. June 25, 2024

Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study). June 25, 2024

Androgen Receptor Splice Variant 7 in Asian Patients With Metastatic Castration-Resistant Prostate Cancer. June 25, 2024

Increasing Diversity, Equity, and Inclusion in Urology Residency Recruitment: Recommendations From the Society of Women in Urology June 24, 2024

Financial Toxicity Among Patients With Metastatic Prostate Cancer: A Mixed Methods Approach to Identify Effective Interventions. June 24, 2024

Prostate Cancer Risk Stratification by Digital Histopathology and Deep Learning. June 24, 2024

Development of an effective predictive screening tool for prostate cancer using the ClarityDX machine learning platform. June 24, 2024

Reasons for Discordance between 68Ga-PSMA-PET and Magnetic Resonance Imaging in Men with Metastatic Prostate Cancer. June 24, 2024

Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies. June 24, 2024

Association of Tumor Genetics with Outcomes in Patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer Treated with 177Lu-PSMA-617 June 21, 2024

Transition from Transrectal to Transperineal MRI-Fusion Prostate Biopsy Does Not Comprise Detection Rates of Clinically Significant Prostate Cancer at a Tertiary Care Center. June 21, 2024

Prognostic Impact and Clinical Implications of Adverse Tumor Grade in Very Favorable Low- and Intermediate-Risk Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy: Experience of a Single Tertiary Referral Center. June 21, 2024

The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancer. June 21, 2024

Corrigendum to "Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostat Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial" [Eur. Eurol. 84(2) (2023) 156-163]. June 21, 2024

Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial. June 21, 2024

Impact of Mental Health Illness Prior to Prostate Cancer Diagnosis on Treatment Received and Prostate Cancer Outcomes June 20, 2024

Germline Gene-Specific Associations in a Large Prostate Cancer Cohort June 20, 2024

Informed Decision-Making About Germline Testing Among Veterans with Advanced Prostate Cancer: A Mixed-Methods Study June 20, 2024

Risk Factors and Contemporary Management Options for Pain and Discomfort Experienced During a Prostate Biopsy. June 20, 2024

Page 51 of 1450